Sage Journals: Discover world-class research

Open access

Research article

First published 2023

The effect of ixekizumab on axial manifestations in patients with psoriatic arthritis from two phase III clinical trials: SPIRIT-P1 and SPIRIT-P2

Atul Deodhar, Dafna Gladman, Rebecca Bolce [...]

Therapeutic Advances in Musculoskeletal Disease

Retricted access

Review article

First published 2026-1

Real-world Evidence of Brodalumab Safety for the Treatment of Psoriasis

Mark Lebwohl, Eingun James Song, Tina Bhutani [...]

Journal of Psoriasis and Psoriatic Arthritis®

Retricted access

Research article

First published 2019-10

Ixekizumab—An Effective and Safe Treatment for Moderate-to-Severe Plaque Psoriasis in Patients Previously Treated With Other IL-17 Inhibitors: Results From IXORA-P

Kim Papp, Andrew Blauvelt, John Sullivan [...]

Journal of Psoriasis and Psoriatic Arthritis®

Retricted access

Review article

First published 2019-11

The Role of IL-17 in Papulopustular Rosacea and Future Directions

Asma Amir Ali, Reid Vender, Ronald Vender

Journal of Cutaneous Medicine and Surgery

Retricted access

Case report

First published 2024-5

Membranous lupus nephritis secondary to secukinumab therapy: A case report and literature review

Yi Zhou, Zhangxue Hu

Lupus

Retricted access

Research article

First published 2023-1

Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway

Wei Jing Loo, Irina Turchin, Vimal H. Prajapati [...]

Journal of Cutaneous Medicine and Surgery

Open access

Research article

First published 2021

The role of ixekizumab in non-radiographic axial spondyloarthritis

Bon San Koo, Tae-Hwan Kim

Therapeutic Advances in Musculoskeletal Disease

Retricted access

Research article

First published 2019-3

Treating to Target(s) With Interleukin-17 Inhibitors

Charles W. Lynde, Jennifer Beecker, Jan Dutz [...]

Journal of Cutaneous Medicine and Surgery

Retricted access

Research article

First published 2011-04

Interleukin-23-Induced Interleukin-23 Receptor Subunit Expression Is Mediated by the Janus Kinase/Signal Transducer and Activation of Transcription Pathway in Human CD4 T Cells

Nor Fazila Che Mat, Xiubo Zhang, Christina Guzzo [...]

Journal of Interferon & Cytokine Research

Retricted access

Review article

First published 2020-1

Interleukin-17 and lupus: enough to be a target? For which patients?

M Robert, P Miossec

Lupus

Search results